636 patents currently held
463 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Of the 463 now held by other companies, 77 name Avient Protective Materials B.V. as their current owner, and 386 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
129
Ending by 2030
Nov 2026
Next term end
512
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2027 · High confidence
Also notable
Ends Nov 2026 · High confidence
Also notable
Ends Sep 2032 · High confidence
Compliant Osteosynthesis Fixation Plate
US 7,931,695
The most cited patent in this portfolio, cited by 1,423 later US patents, top 1% of utility patents granted in 2011 in our data. Protection runs to 2027.
Compressed Porous Materials Suitable for Implant
US 7,723,395
Cited by 206 later US patents, top 5% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2026.
Eicosapentaenoic Acid-Producing Microorganisms, Fatty Acid Compositions, and Methods of Making and Uses Thereof
US 9,045,785
Cited by 30 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Formerly held, still cited
Notable
Ends Jan 2039 · High confidence
Cited by 6 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2039.
now held by Stratasys Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 16 to 30, 2026 · next Nov 16
- 16 fees due Dec 2 to 30, 2026 · next Dec 2
- 7 fees due Jan 2 to 30, 2027 · next Jan 2
- 17 fees due Feb 1 to 27, 2027 · next Feb 1
- 6 fees due Mar 5 to 22, 2027 · next Mar 5
- 12 fees due Apr 3 to 29, 2027 · next Apr 3
- 15 fees due May 3 to 26, 2027 · next May 3
- 11 fees due Jun 1 to 30, 2027 · next Jun 1
- 15 fees due Jul 5 to 26, 2027 · next Jul 5
- 19 fees due Aug 2 to 27, 2027 · next Aug 2
- 9 fees due Sep 12 to 30, 2027 · next Sep 12
- 16 fees due Oct 2 to 28, 2027 · next Oct 2
- 2 fees due Nov 7, 2027
Recent changes
- 16 of the patents on this record were granted since Aug 18, 2026
- 23 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 512 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Fermentative Glycerol-Free Ethanol Production | 9 in force | to Dec 2032 |
| Eicosapentaenoic Acid-Producing Microorganisms, Fatty Acid Compositions, and Methods of Making and Uses Thereof | 6 in force | to Nov 2032 |
| Thraustochytrids, Fatty Acid Compositions, and Methods of Making and Uses Thereof | 5 in force | to Apr 2031 |
| Method for the Prevention or Reduction of Haze in Beverages | 5 in force | to Oct 2029 |
| Adipose Tissue Centrifuge and Method of Use | 4 in force | to Sep 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,723,395 | Compressed Porous Materials Suitable for Implant In force · High confidence | In force | High confidence | |
| US 8,293,712 | Cosmetic Composition for Stimulating the Synthesis of Proteins of the Basement Membrane In force · High confidence | In force | High confidence | |
| US 7,897,822 | Process for Ubiquinone Intermediates In force · High confidence | In force | High confidence | |
| US 8,257,944 | Modified Transketolase and Use Thereof In force · High confidence | In force | High confidence | |
| US 7,674,826 | Novel Use of a Nutraceutical Compositions in Animal Feed In force · High confidence | In force | High confidence | |
| US 7,931,695 | Compliant Osteosynthesis Fixation Plate In force · High confidence | In force | High confidence | |
| US 7,879,804 | Blood Pressure Lowering Peptides in a Single Enzymatic Step In force · High confidence | In force | High confidence | |
| US 7,691,297 | Process for the Manufacture of Powderous Preparations of Fat-Soluble Substances In force · High confidence | In force | High confidence | |
| US 7,718,205 | Process for Preparation of Calcium-D-Pantothenate In force · High confidence | In force | High confidence | |
| US 9,011,948 | Enzyme Preparations Yielding a Clean Taste In force · High confidence | In force | High confidence |
Also on record, not counted in the 636: 463 patents in force now held by others · 1,045 patents ended · 409 applications pending · 1,676 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.